FSHD1

Clinical trials for FSHD1 explained in plain language.

Never miss a new study

Get alerted when new FSHD1 trials appear

Sign up with your email to follow new studies for FSHD1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet finished but already full! 1 Completed 1

New hope for FSHD: Long-Term drug safety trial underway

Disease control Ongoing

This study looks at the long-term safety and effectiveness of a drug called AOC 1020 for people with FSHD, a genetic disease that causes muscle weakness. About 84 adults who completed a previous study will receive the drug through an IV. The main goal is to check for side effects…

Matched conditions: FSHD1

Phase: PHASE2 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control

Last updated May 17, 2026 05:03 UTC

FSHD1

Get alerted when new FSHD1 trials appear

New hope for FSHD: Long-Term drug safety trial underway